INFORMATION FOR
News
A study recently published in The Lancet details how the warning symptoms of cardiac arrest are sex specific.
A novel application of deep learning could detect severe aortic stenosis early, researchers say.
Three investigators in training from the Yale Cardiovascular Data Science (CarDS) Lab were invited to present their research results along with other finalists at the 2023 American Heart Association (AHA) Scientific Sessions.
A new deep learning application provides an automated screening strategy for left ventricular (LV) systolic dysfunction. It can detect previously hidden conditions from electrocardiogram images.
Jennifer M. Kwan, MD, PhD, seeks to understand how a somatic mutation condition known as CHIP increases the risk of heart disease.
The Innovative Project Award will support high-potential research that could lead to critical discoveries for people with sarcoidosis
A Yale-led study sheds light on a previously unknown inflammatory process.
A recent study in JAMA Network Open found that fewer than 1 in 4 people with or at risk for cardiovascular disease (CVD) use wearable devices, and only half of those who wear them do so consistently.
Attila Feher, MD, PhD, has been selected for the American Society of Nuclear Cardiology (ASNC) Leadership Development Program.
Women's Health Research at Yale announces recipients of 2023 Pilot Project Program Grants
Twenty years after a study funded by Women's Health Research at Yale uncovered that women face the risk of poorer outcomes after heart bypass surgery, new research finds the increased risk for women persists despite improved overall outcomes. But, with increased representation of women in clinical research and innovation in targets of study, we can overcome the gender gap.
Carlos Mena-Hurtado, MD, was appointed to serve on the Society for Vascular Surgery Patient Safety Organization (SVS PSO) Governing Council.
Carlos Mena-Hurtado, MD, received a Clinical Coordinating Center Rally award for outstanding leadership in the CREST-2 trial.
John Spertus, MD, MPH, an expert on the measurement of quality of care and health status in cardiovascular disease, will speak at the virtual VAMOS Research Meeting on Tuesday, April 18.
When untreated, patients with Chagas disease are at risk for arrhythmias, dilated cardiomyopathy, or heart failure.
The Council on Peripheral Vascular Disease expert perspective provides interventions to improve PAD outcomes and patient satisfaction.
The Evolut Low-Risk Trial suggests that the initial benefit of TAVR remained consistent over the first three years
In the United States, a significant number of patients continue to struggle with persistent hypertension.
We are pleased to offer a robust and supportive educational training environment to foster research skill development in undergraduate researchers.
Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.